C3 Clinical Cell Culture - Print version

ReCell®

ReCell® is an innovative medical device for harvesting autologous skin cells. Developed as an 'off the shelf' kit, ReCell® enables a thin split thickness biopsy, taken at the time of the procedure, to be processed into an immediate cell population for delivery onto the wound surface.

ReCell® can be used to treat a number of injuries:

Advantages include:

Estimates indicate that approximate two to three million patients could benefits from ReCell® each year.

Click here to learn more about ReCell®